Identification of Novel Susceptibility Loci for Kawasaki Disease in a Han Chinese Population by a Genome-Wide Association Study
暂无分享,去创建一个
Fuu-Jen Tsai | Li-Ching Chang | Yuan-Tsong Chen | F. Huang | N. Chiu | Yuan-Tsong Chen | Yi-Ching Lee | Chien-Hsiun Chen | Li-Ching Chang | Jer-Yuarn Wu | Li-Min Huang | Yann-Jinn Lee | Hsin Chi | Li-Min Huang | Nan-Chang Chiu | Fu-Yuan Huang | Chien-Hsiun Chen | Jer-Yuarn Wu | Ming-Ren Chen | Yann-Jinn Lee | Ming-Ren Chen | Jeng-Sheng Chang | Yi-Ching Lee | Yi-Min Liu | H. Chi | Hsiang-Hua Wang | Yi-Min Liu | Jeng‐Sheng Chang | F. Tsai | Hsiang-Hua Wang
[1] Jimmy K. Eng,et al. Quantitative Phosphoproteomic Analysis of T Cell Receptor Signaling Reveals System-Wide Modulation of Protein-Protein Interactions , 2009, Science Signaling.
[2] Feras Hawari,et al. An Aminopeptidase, ARTS-1, Is Required for Interleukin-6 Receptor Shedding* , 2003, Journal of Biological Chemistry.
[3] Pei-Jer Chen,et al. Epidemiologic Features of Kawasaki Disease in Taiwan, 2003–2006 , 2009, Pediatrics.
[4] S. Crawford,et al. IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease. , 2000, The Journal of infectious diseases.
[5] A. Goldberg,et al. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a "molecular ruler" mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] Yoshihiro Onouchi,et al. Molecular Genetics of Kawasaki Disease , 2009, Pediatric Research.
[7] Ann Saada,et al. Antenatal mitochondrial disease caused by mitochondrial ribosomal protein (MRPS22) mutation , 2007, Journal of Medical Genetics.
[8] Feras Hawari,et al. Shedding of the Type II IL-1 Decoy Receptor Requires a Multifunctional Aminopeptidase, Aminopeptidase Regulator of TNF Receptor Type 1 Shedding , 2003, The Journal of Immunology.
[9] F. Tsai,et al. Polymorphism of Angiotensin-1 Converting Enzyme Gene and Kawasaki Disease , 2004, Pediatric Cardiology.
[10] Yu-Lung Lau,et al. Inflammatory Gene Polymorphisms and Susceptibility to Kawasaki Disease and Its Arterial Sequelae , 2008, Pediatrics.
[11] Walter R Wilson,et al. Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association , 2004, Circulation.
[12] Anbupalam Thalamuthu,et al. A Genome-Wide Association Study Identifies Novel and Functionally Related Susceptibility Loci for Kawasaki Disease , 2009, PLoS genetics.
[13] F. Dedeoglu,et al. Update on pediatric vasculitis , 2005, Current opinion in pediatrics.
[14] David M. Evans,et al. Investigating the genetic association between ERAP1 and ankylosing spondylitis , 2009, Human molecular genetics.
[15] H. Yanagawa,et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. , 2001, Pediatrics.
[16] Yusuke Nakamura,et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms , 2008, Nature Genetics.
[17] Yusuke Nakamura,et al. A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12 , 2006, Journal of Human Genetics.
[18] H Yanagawa,et al. Results of the nationwide epidemiologic survey of Kawasaki disease in 1995 and 1996 in Japan. , 1998, Pediatrics.
[19] S. Crawford,et al. Detection of antigen in bronchial epithelium and macrophages in acute Kawasaki disease by use of synthetic antibody. , 2004, The Journal of infectious diseases.
[20] S. Koike,et al. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. , 1975, The Journal of pediatrics.
[21] K Hashino,et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. , 1996, Circulation.
[22] J-S Chang,et al. HLA-E gene polymorphism associated with susceptibility to Kawasaki disease and formation of coronary artery aneurysms. , 2009, Arthritis and rheumatism.
[23] K. Yabuta,et al. Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-gamma in Kawasaki disease involved coronary-artery lesions. , 1990, Clinical immunology and immunopathology.
[24] Sang Bum Lee,et al. Epidemiological features of Kawasaki disease in Korea, 2006–2008 , 2011, Pediatrics international : official journal of the Japan Pediatric Society.
[25] H. Jäck,et al. IgA plasma cells in vascular tissue of patients with Kawasaki syndrome. , 1997, Journal of Immunology.
[26] W. Pan,et al. Han Chinese Cell and Genome Bank in Taiwan: Purpose, Design and Ethical Considerations , 2006, Human Heredity.
[27] T. Kawasaki,et al. HLA antigens in Kawasaki disease. , 1978, Pediatrics.
[28] B. Chiang,et al. Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor alpha among patients with Kawasaki disease. , 1992, The Journal of pediatrics.
[29] Christian A. Combs,et al. Identification of ARTS-1 as a novel TNFR1-binding protein that promotes TNFR1 ectodomain shedding , 2002 .
[30] Chin‐Yun Lee,et al. Epidemiologic Features of Kawasaki Disease in Taiwan, 1996–2002 , 2004, Pediatrics.